medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2015, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2015; 60 (1)

Proximal muscle weakness as the first manifestation of an endocrine disease

Moreno-del Castillo MC, Videgaray-Ortega F,Gómez-Romero P, Joya-Galeana JG, Zulaica-Richard HA

Language: Spanish
References: 14
Page: 45-48
PDF size: 209.95 Kb.


ABSTRACT

Some metabolic diseases may present with musculoskeletal disorders, such as endocrine myopathy. Endocrine diseases should be considered in the differential diagnosis of patients with proximal muscle weakness without elevated muscle enzymes and associated with an uncommon electromyogram myopathic pattern. A case of a previously healthy patient presenting with proximal muscle weakness and fever is reported; an endocrine myopathy disease was suspected and a diagnosis of Graves’ disease was made, coupled with deficiency of vitamin D and urinary tract infection.


REFERENCES

  1. Lioté F, Orcel P. Osteoarticular disorders of endocrine origin. Baillieres Best Pract Res Clin Rheumatol. 2000; 14 (2): 251-276.

  2. Ruff RL, Weissmann J. Endocrine myopathies. Neurol Clin. 1988; 6 (3): 575-592.

  3. Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013; 34 (1): 33-83.

  4. Brent GA. Graves’ disease. N Engl J Med. 2008; 358: 2594-2605.

  5. Wheetman AP. Graves’ disease. N Engl J Med. 2000; 343 (17): 1236-1248.

  6. Whitfield AG, Hudson WA. Chronic thyrotoxic myopathy. Q J Med. 1961; 30: 257-267.

  7. Erkintalo M, Bendahan D, Mattéi JP, Fabreguettes C, Vague P, Cozzone PJ. Reduced metabolic efficiency of skeletal muscle energetics in hyperthyroid patients evidenced quantitatively by in vivo phosphorus-31 magnetic resonance spectroscopy. Metabolism. 1998; 47: 769-776.

  8. Drachman DB. Myasthenia gravis and the thyroid gland. N Engl J Med. 1962; 266: 330-333.

  9. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med. 1982; 142: 1362-1364.

  10. Bartalena L. Prevention of Graves’ ophthalmopathy. Best Pract Res Clin Endocrinol Metab. 2012; 26: 371-379.

  11. Vaidya B, Williams GR, Abraham P, Pearce SH. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clin Endocrinol (Oxf). 2008; 68: 814-820.

  12. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003; 348: 727-734.

  13. Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl Med. 2009; 360: 2328-2339.

  14. Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2010; 17 (3): 217-223.




2020     |     www.medigraphic.com